Sloane Robinson, the once-$20 billion emerging markets hedge fund that converted to a family office in 2020, is staging a comeback with a new long-short equity strategy that's already trouncing broader markets.

The SR Ocellus Fund, launched in January 2024, has surged 15.4% year-to-date through February - and tacked on another ~6% in March - as its unorthodox a